Cargando…
The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR Signaling
SIMPLE SUMMARY: Despite the clinical efficacy of so-called immune checkpoint inhibitors (ICIs) in various cancers, some cancer types, including epithelial ovarian cancer (EOC), do not effectively respond to current therapeutics. Thus, the identification of new immune checkpoints that regulate T cell...
Autores principales: | Bilemjian, Vrouyr, Vlaming, Martijn R., Álvarez Freile, Jimena, Huls, Gerwin, De Bruyn, Marco, Bremer, Edwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264967/ https://www.ncbi.nlm.nih.gov/pubmed/35804934 http://dx.doi.org/10.3390/cancers14133164 |
Ejemplares similares
-
Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival
por: Vlaming, Martijn, et al.
Publicado: (2022) -
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties
por: Vlaming, Martijn, et al.
Publicado: (2021) -
EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells
por: Melo, Vinicio, et al.
Publicado: (2023) -
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and therapeutics
por: Álvarez Freile, Jimena, et al.
Publicado: (2023) -
CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
por: Freile, Jimena Álvarez, et al.
Publicado: (2022)